Literature DB >> 20214126

Appropriateness of hospital admissions in general hospitals in Egypt.

M Al-Tehewy1, E Shehad, M Al Gaafary, M Al-Houssiny, D Nabih, B Salem.   

Abstract

We measured the rate of inappropriate admissions, and associated factors, in 3 general hospitals in Egypt. A total of 1191 admissions were reviewed using the Appropriateness Evaluation Protocol for adult patients and the Pediatric Appropriateness Evaluation Protocol for paediatric patients. Inappropriate admissions were 66.3% and 78.9% of admissions in the surgery departments of 2 hospitals compared with 1.9% in the 3rd hospital that followed a specific admission protocol for elective surgery. The paediatrics department had the lowest rates of inappropriate admissions in all hospitals (0%, 1.0% and 1.9%). On logistic regression analysis, the route of admission was the only factor significantly associated with inappropriate admissions in the departments of surgery, obstetrics/gynaecology and internal medicine.

Entities:  

Mesh:

Year:  2009        PMID: 20214126

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  3 in total

Review 1.  Evidence for overuse of medical services around the world.

Authors:  Shannon Brownlee; Kalipso Chalkidou; Jenny Doust; Adam G Elshaug; Paul Glasziou; Iona Heath; Somil Nagpal; Vikas Saini; Divya Srivastava; Kelsey Chalmers; Deborah Korenstein
Journal:  Lancet       Date:  2017-01-09       Impact factor: 79.321

2.  Investigating the Appropriateness of Admission and Hospitalization at a Teaching Hospital: A Case of a Developing Country.

Authors:  Mahmood Nekoei Moghadam; Mohammadreza Amiresmaili; Reza Goudarzi; Saeed Amini; Sajad Khosravi
Journal:  Iran J Public Health       Date:  2017-12       Impact factor: 1.429

3.  Prevalence and associated factors of inappropriate hospital admissions and days of children in a secondary hospital in Shanghai, China.

Authors:  Wenwei Liu; Huimin Zhang; Haichen Zhang; Tongzhou Lyu; Suwei Yuan
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.